Biotech firm gets €5.2m investment

A start-up behind novel new technology to treat strokes has secured investment of €5.2 million in a funding round led by Fountain Healthcare Partners and Delta Partners.

14th July, 2012
Biotech firm gets €5.2m investment
Justin Lynch of Fountain Healthcare Partners, left, with Eamon Brady and John O'Shaughnessy of Neuravi. Photo: Andrew Downes

Company: Neuravi

**Done Deal:** €5.2 million

**Staff:** four

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Get basic

*New subscribers only

You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

2 Yearly

€315

€248

Unlimited Access for 2 Years

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

The year in review

Legacy Richie Oakley 1 year ago

Newsround: What Thursday’s papers say

Legacy Leanna Byrne 5 years ago

More cycle routes, expansion of Luas to Bray and new bus network proposed

Legacy Digital Desk 5 years ago